The field of antibody-based therapeutics remains ripe for exploration as it encompasses novel developments for cancer, antibody-drug conjugates and bispecific antibodies. The weeklong Antibody Therapeutics pipeline divulges R&D strategies, clinical results and efficacy data and reveals the intricacies of these promising molecules as well as the exciting results that international research efforts have achieved.
Cancer Targets for Antibody Therapeutics
Bispecific Antibody Therapeutics
RECOMMENDED DINNER SHORT COURSES*
SC1: Production Challenges for Complex Biologics: ADCs, Bispecifics and Fusion Proteins
SC2: The S-Score System: A Tool for Identifying New Cancer Targets for Antibody-Drug Therapy
SC8: Affecting Effector Function: Engineering the Fc Region
*Separate registration required. Click here for more details.